Tempest Therapeutics, Inc. (TPST) Names Nancy Freda-Smith to Board, Chairs Audit

Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors and named her Chair of the Audit Committee.Material DetailsContext by AI AnalystThis is an early-stage governance move for a clinical biotech aiming to scale and manage risk. A larger catalyst would be financing, partnership…